Advertisement

Elevated hydrostatic pressure stimulates ATP release which mediates activation of the NLRP3 inflammasome via P2X4 in rat urothelial cells

  • Cody L. Dunton
  • J. Todd Purves
  • Francis M. HughesJr.
  • Huixia Jin
  • Jiro Nagatomi
Urology - Original Paper

Abstract

Partial bladder outlet obstruction (pBOO) is a prevalent urological condition commonly accompanied by increased intravesical pressure, inflammation, and fibrosis. Studies have demonstrated that pBOO results in increased NLRP3 inflammasome and caspase-1 activation and that ATP is released from urothelial cells in response to elevated pressure. In the present study, we investigated the role of elevated pressure in triggering caspase-1 activation via purinergic receptors activation in urothelial cells. Rat urothelial cell line, MYP3 cells, was subjected to hydrostatic pressures of 15 cmH2O for 60 min, or 40 cmH2O for 1 min to simulate elevated storage and voiding pressure conditions, respectively. ATP concentration in the supernatant media and intracellular caspase-1 activity in cell lysates were measured. Pressure experiments were repeated in the presence of antagonists for purinergic receptors to determine the mechanism for pressure-induced caspase-1 activation. Exposure of MYP3 cells to both pressure conditions resulted in an increase in extracellular ATP levels and intracellular caspase-1 activity. Treatment with P2X7 antagonist led to a decrease in pressure-induced ATP release by MYP3 cells, while P2X4 antagonist had no effect but both antagonists inhibited pressure-induced caspase-1 activation. Moreover, when MYP3 cells were treated with extracellular ATP (500 µM), P2X4 antagonist inhibited ATP-induced caspase-1 activation, but not P2X7 antagonist. We concluded that pressure-induced extracellular ATP in urothelial cells is amplified by P2X7 receptor activation and ATP-induced-ATP release. The amplified ATP signal then activates P2X4 receptors, which mediate activation of the caspase-1 inflammatory response.

Keywords

Hydrostatic pressure NLRP3 Inflammasome Inflammation Purinergic receptors P2X4 P2X7 Pressure mechanobiology 

Notes

Acknowledgements

The authors would like to thank Julie Fuller and the Substrate Services Core and Research Support Services (SCRSS) in the Department of Surgery for their histological embedding and sectioning. We also thank the Light Microscopy Care Facility and Yasheng Gao for help imaging. Both core facilities are at Duke University.

Author contributions

JTP, FMH, and JN conceived the project; CLD, JTP, FMH, and JN designed experiments; CLD, FMH, and HJ performed experiments; CLD analyzed data; CLD, JTP, FMH, and JN interpreted results of experiments; CLD and FMH prepared figures; CLD. drafted manuscript; CLD, JTP, FMH, and JN edited and revised manuscript. JTP, FMH, and JN approved final version of manuscript.

Funding

Funding was provided by National Institute of Diabetes and Digestive and Kidney Diseases (Grant No. R01DK103534), National Institutes of Health (Grant No. P20GM103444), and National Science Foundation (Grant No. 1264579).

References

  1. 1.
    Irwin DE, Kopp ZS, Agatep B et al (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 108:1132–1138CrossRefPubMedGoogle Scholar
  2. 2.
    Metcalfe PD, Wang J, Jiao H et al (2010) Bladder outlet obstruction: progression from inflammation to fibrosis. BJU Int 106:1686–1694CrossRefPubMedGoogle Scholar
  3. 3.
    Andersson K-E, Gratzke C (2007) Pharmacology of α1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol 4:368CrossRefPubMedGoogle Scholar
  4. 4.
    Rossi C, Kortmann BB, Sonke GS et al (2001) alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it. J Urol 165:38–41CrossRefPubMedGoogle Scholar
  5. 5.
    Malmgren A, Uvelius B, Andersson KE, Andersson PO (1990) On the reversibility of functional bladder changes induced by infravesical outflow obstruction in the rat. J Urol 143:1026–1031CrossRefPubMedGoogle Scholar
  6. 6.
    Gabella G, Uvelius B (1994) Reversal of muscle hypertrophy in the rat urinary bladder after removal of urethral obstruction. Cell Tissue Res 277:333–339CrossRefPubMedGoogle Scholar
  7. 7.
    Chai TC, Gemalmaz H, Andersson K-E et al (1999) Persistently increased voiding frequency despite relief of bladder outlet obstruction. J Urol 161:1689–1693CrossRefPubMedGoogle Scholar
  8. 8.
    Jin L-H, Andersson K-E, Han J-U et al (2011) Persistent detrusor overactivity in rats after relief of partial urethral obstruction. Am J Physiol Integr Comp Physiol 301:R896–R904CrossRefGoogle Scholar
  9. 9.
    Oka M, Fukui T, Ueda M et al (2009) Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction. J Urol 182:382–390CrossRefPubMedGoogle Scholar
  10. 10.
    Hughes FM, Hill HM, Wood CM et al (2016) The NLRP3 inflammasome mediates inflammation produced by bladder outlet obstruction. J Urol 195:1598–1605CrossRefPubMedGoogle Scholar
  11. 11.
    Shiina K, Hayashida K-I, Ishikawa K, Kawatani M (2016) ATP release from bladder urothelium and serosa in a rat model of partial bladder outlet obstruction. Biomed Res 37:299–304CrossRefPubMedGoogle Scholar
  12. 12.
    Han JH, Yu HS, Lee JY et al (2015) Simple modification of the bladder outlet obstruction index for better prediction of endoscopically-proven prostatic obstruction: a preliminary study. PLoS ONE 10:e0141745CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Hughes FM, Vivar NP, Kennis JG et al (2013) Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation. Am J Physiol Physiol 306:F299–F308CrossRefGoogle Scholar
  14. 14.
    Pandita RAJK, Fujiwara M, Alm PER, Andersson K-E (2000) Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction. J Urol 164:1385–1389CrossRefPubMedGoogle Scholar
  15. 15.
    Beckel JM, Daugherty SL, Tyagi P et al (2015) Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder. J Physiol 593:1857–1871CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Vlaskovska M, Kasakov L, Rong W et al (2001) P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 21:5670–5677CrossRefPubMedGoogle Scholar
  17. 17.
    Olsen SM, Stover JD, Nagatomi J (2011) Examining the role of mechanosensitive ion channels in pressure mechanotransduction in rat bladder urothelial cells. Ann Biomed Eng 39:688–697CrossRefPubMedGoogle Scholar
  18. 18.
    Mochizuki T, Sokabe T, Araki I et al (2009) The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem 284:21257–21264CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Birder LA, Nakamura Y, Kiss S et al (2002) Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5:856CrossRefPubMedGoogle Scholar
  20. 20.
    Riteau N, Gasse P, Fauconnier L et al (2010) Extracellular ATP is a danger signal activating P2X7 receptor in lung inflammation and fibrosis. Am J Respir Crit Care Med 182:774–783CrossRefPubMedGoogle Scholar
  21. 21.
    Cauwels A, Rogge E, Vandendriessche B et al (2014) Extracellular ATP drives systemic inflammation, tissue damage and mortality. Cell Death Dis 5:e1102CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Lamkanfi M, Dixit VM (2011) Modulation of inflammasome pathways by bacterial and viral pathogens. J Immunol 187:597–602CrossRefPubMedGoogle Scholar
  23. 23.
    Mariathasan S, Weiss DS, Newton K et al (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228CrossRefPubMedGoogle Scholar
  24. 24.
    Schroder K, Tschopp J (2010) The inflammasomes. Cell 140:821–832CrossRefPubMedGoogle Scholar
  25. 25.
    Lutolf R, Hughes FM, Purves JT (2018) NLRP3/IL-1β mediates denervation during bladder outlet obstruction in rats. Neurourol Urodyn 37:952–959CrossRefPubMedGoogle Scholar
  26. 26.
    Hughes FM, Sexton SJ, Jin H et al (2017) Bladder fibrosis during outlet obstruction is triggered through the NLRP3 inflammasome and the production of IL-1β. Am J Physiol Physiol 313:F603–F610CrossRefGoogle Scholar
  27. 27.
    Kawamata H, Kameyama S, Nan L et al (1993) Effect of epidermal growth factor and transforming growth factor β1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines. Int J Cancer 55:968–973CrossRefPubMedGoogle Scholar
  28. 28.
    Cohen SM, Arnold LL, Uzvolgyi E et al (2002) Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem Res Toxicol 15:1150–1157CrossRefPubMedGoogle Scholar
  29. 29.
    Nascimento MG, Suzuki S, Wei M et al (2008) Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro. Toxicology 249:69–74CrossRefPubMedGoogle Scholar
  30. 30.
    Hughes FM, Turner DP, Todd Purves J (2015) The potential repertoire of the innate immune system in the bladder: expression of pattern recognition receptors in the rat bladder and a rat urothelial cell line (MYP3 cells). Int Urol Nephrol 47:1953–1964CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Stover J, Nagatomi J (2007) Cyclic pressure stimulates DNA synthesis through the PI3K/Akt signaling pathway in rat bladder smooth muscle cells. Ann Biomed Eng 35:1585–1594CrossRefPubMedGoogle Scholar
  32. 32.
    Balázs B, Dankó T, Kovács G et al (2013) Investigation of the inhibitory effects of the benzodiazepine derivative, 5-BDBD on P2X4 purinergic receptors by two complementary methods. Cell Physiol Biochem 32:11–24CrossRefPubMedGoogle Scholar
  33. 33.
    Negoro H, Urban-Maldonado M, Liou LS et al (2014) Pannexin 1 channels play essential roles in urothelial mechanotransduction and intercellular signaling. PLoS ONE 9:e106269CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Sadaharu U, Takeshi K, Tatsuo F (2018) Effects of PPADS and suramin on contractions and cytoplasmic Ca2+ changes evoked by AP4A, ATP and α,β-methylene ATP in guinea-pig urinary bladder. Br J Pharmacol 117:698–702Google Scholar
  35. 35.
    Wang Y, Roman R, Lidofsky SD, Fitz JG (1996) Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc Natl Acad Sci 93:12020–12025CrossRefPubMedGoogle Scholar
  36. 36.
    Truschel ST, Wang E, Ruiz WG et al (2002) Stretch-regulated exocytosis/endocytosis in bladder umbrella cells. Mol Biol Cell 13:830–846CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Silverman W, Locovei S, Dahl G (2008) Probenecid, a gout remedy, inhibits pannexin 1 channels. Am J Physiol Physiol 295:C761–C767CrossRefGoogle Scholar
  38. 38.
    Nitti VW (2005) Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol 7:S14–S21PubMedPubMedCentralGoogle Scholar
  39. 39.
    Adinolfi E, Raffaghello L, Giuliani AL et al (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72:2957–2969CrossRefPubMedGoogle Scholar
  40. 40.
    Chen K, Zhang J, Zhang W et al (2013) ATP-P2X4 signaling mediates NLRP3 inflammasome activation: a novel pathway of diabetic nephropathy. Int J Biochem Cell Biol 45:932–943CrossRefPubMedGoogle Scholar
  41. 41.
    Cook SP, Vulchanova L, Hargreaves KM et al (1997) Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature 387:505–508CrossRefPubMedGoogle Scholar
  42. 42.
    Nakagomi H, Yoshiyama M, Mochizuki T et al (2016) Urothelial ATP exocytosis: regulation of bladder compliance in the urine storage phase. Sci Rep 6:29761CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Pelegrin P, Surprenant A (2006) Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor. EMBO J 25:5071–5082CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Birder LA, Ruan HZ, Chopra B et al (2004) Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol—Ren Physiol 287:F1084–F1091CrossRefGoogle Scholar
  45. 45.
    McGaraughty S, Chu KL, Namovic MT et al (2007) P2X7-related modulation of pathological nociception in rats. Neuroscience 146:1817–1828CrossRefPubMedGoogle Scholar
  46. 46.
    Boudreault F, Grygorczyk R (2002) Cell swelling-induced ATP release and gadolinium-sensitive channels. Am J Physiol Physiol 282:C219–C226CrossRefGoogle Scholar
  47. 47.
    Boudreault F, Grygorczyk R (2004) Cell swelling-induced ATP release is tightly dependent on intracellular calcium elevations. J Physiol 561:499–513CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Hazama A, Shimizu T, Ando-Akatsuka Y et al (1999) Swelling-induced, Cftr-independent Atp release from a human epithelial cell line. J Gen Physiol 114:525–533CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Reigada D, Lu W, Zhang M, Mitchell CH (2008) Elevated pressure triggers a physiological release of ATP from the retina: possible role for pannexin hemichannels. Neuroscience 157:396–404CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Richter K, Kiefer KP, Grzesik BA et al (2013) Hydrostatic pressure activates ATP-sensitive K+ channels in lung epithelium by ATP release through pannexin and connexin hemichannels. FASEB J 28:45–55CrossRefPubMedGoogle Scholar
  51. 51.
    Wang ECY, Lee J-M, Ruiz WG et al (2005) ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Investig 115:2412–2422CrossRefPubMedGoogle Scholar
  52. 52.
    Sekar P, Huang D-Y, Chang S-F, Lin W-W (2018) Coordinate effects of P2X7 and extracellular acidification in microglial cells. Oncotarget 9:12718–12731CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Yaron JR, Gangaraju S, Rao MY et al (2015) K+ regulates Ca2+ to drive inflammasome signaling: dynamic visualization of ion flux in live cells. Cell Death Dis 6:e1954CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Draganov D, Gopalakrishna-Pillai S, Chen Y-R et al (2015) Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Sci Rep 5:16222CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Kahlenberg JM, Dubyak GR (2004) Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am J Physiol Physiol 286:C1100–C1108CrossRefGoogle Scholar
  56. 56.
    Mezzaroma E, Toldo S, Farkas D et al (2011) The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. PNAS 108:19725–19730CrossRefPubMedGoogle Scholar
  57. 57.
    Vonend O, Turner CM, Chan CM et al (2004) Glomerular expression of the ATP-sensitive P2X7 receptor in diabetic and hypertensive rat models. Kidney Int 66:157–166CrossRefPubMedGoogle Scholar
  58. 58.
    Zhao J, Wang H, Dai C et al (2013) P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway. Arthritis Rheum 65:3176–3185CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Vilaysane A, Chun J, Seamone ME et al (2010) The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 21:1732–1744CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Glass R, Loesch A, Bodin P, Burnstock G (2002) P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells. Cell Mol Life Sci C 59:870–881CrossRefGoogle Scholar
  61. 61.
    LS A, AP S, XJ X et al (2011) P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers. Br J Pharmacol 163:1069–1077CrossRefGoogle Scholar
  62. 62.
    Stojilkovic SS, Yan Z, Obsil T, Zemkova H (2010) Structural insights into the function of P2X4: an ATP-gated cation channel of neuroendocrine cells. Cell Mol Neurobiol 30:1251–1258CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    He Y, Hara H, Nunez G (2016) Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci 41:1012–1021CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Hornung V, Latz E (2010) Critical functions of priming and lysosomal damage for NLRP3 activation. Eur J Immunol 40:620–623CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Inouye B, Hughes FM, Sexton S, Purves JT (2018) The emerging role of inflammasomes as central mediators in inflammatory bladder pathology. Curr Urol 11:57–72CrossRefPubMedGoogle Scholar
  66. 66.
    Savage C, Lopez-Castejon G, Denes A, Brough D (2012) NLRP3-inflammasome activating DAMPs stimulate and inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front Immunol 3:288CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Hughes FM, Hirsham N, Inouye B et al (2018) The NLRP3 inflammasome is required for the development of diabetic bladder dysfunction and causes symptom-specific changes in neuronal innervationGoogle Scholar
  68. 68.
    Franceschini A, Capece M, Chiozzi P et al (2015) The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein. FASEB J 29:2450–2461CrossRefPubMedGoogle Scholar
  69. 69.
    Di Virgilio F (2007) Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol Sci 28:465–472CrossRefPubMedGoogle Scholar
  70. 70.
    Di Virgilio F (2013) The therapeutic potential of modifying inflammasomes and NOD-Like receptors. Pharmacol Rev 65:872–905CrossRefPubMedGoogle Scholar
  71. 71.
    Grailer JJ, Canning BA, Kalbitz M et al (2014) Critical role for the NLRP3 inflammasome during acute lung injury. J Immunol 192:5974–5983CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Liu H-D, Li W, Chen Z-R et al (2013) Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem Res 38:2072–2083CrossRefPubMedGoogle Scholar
  73. 73.
    Takahashi M (2014) NLRP3 inflammasome as a novel player in myocardial infarction. Int Heart J 55:101–105CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Cody L. Dunton
    • 1
  • J. Todd Purves
    • 1
    • 2
    • 3
  • Francis M. HughesJr.
    • 1
    • 2
  • Huixia Jin
    • 2
  • Jiro Nagatomi
    • 1
  1. 1.Department of BioengineeringClemson UniversityClemsonUSA
  2. 2.Division of Urology, Department of SurgeryDuke University Medical CenterDurhamUSA
  3. 3.Department of PediatricsDuke University Medical CenterDurhamUSA

Personalised recommendations